Contact Us

HOTEL NEWS

Everise Honored as Leading Disability Employer 2024 by National Organization on Disability

Oct 15, 2024

PLANTATION,Fla.,Oct. 14,2024-- Global healthcare customer experience company Everise today announced that it has been recognized by the National Organization on Disability (NOD) as a Leading Disabili

Metabolon Launches New "Guide to Multiomics" and Accompanying Multiomics Webinar

Oct 15, 2024

Metabolon\'s new multiomics guide and webinar demystify complex omics technologies and illuminate how integrated multiomics is transforming life science research

Asia Pacific Breweries Singapore Partners Migrants Workers' Centre to Champion Community Connections

Oct 15, 2024

SINGAPORE,Oct. 14,2024-- Asia Pacific Breweries Singapore (APB) is thrilled to announce the launch of its latest social impact initiative,\'Worlds Together\',which seeks to connect communities and lay

Tsingke Shines at Cell & Gene Therapy International 2024

Oct 15, 2024

BEIJING and BOSTON,Oct. 14,2024-- BeijingTsingke Biotech Co.,Ltd. recently concluded a successful exhibition at CGTI2024 in Boston. This premier event attracted over 3,200 global attendees,including p

Global Sae-A Group Completes Construction of 36,000-Spindle Third Spinning Mill in Costa Rica

Oct 15, 2024

CARTAGO,Costa Rica,Oct. 14,2024-- GlobalSae-A Group,the holding company of Sae-A Trading,one of the world\'s largest apparel manufacturer,held an opening ceremony for its third spinning mill in Costa

PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration

Oct 15, 2024

Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403,preparing for multiple ascending dose 4 mg cohort.

1 ... 136 137 138 139 140 141 142 ... 226